Evidence map›Paper›PMID 21325631›Full record

ArticleMolecular biology of the cell2011

Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited.

Tamara A Potapova, Sushama Sivakumar, Jennifer N Flynn, Rong Li, Gary J Gorbsky

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 156 citations in OpenAlex.

  1. Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. DNA damage checkpoint execution and the rules of its disengagement.Frontiers in cell and developmental biology · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nanoparticles target intimal macrophages in atherosclerotic lesions.Nanomedicine : nanotechnology, biology, and medicine · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Tamara A PotapovaOklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. tpo@stowers.org
Sushama Sivakumar
Jennifer N Flynn
Rong Li
Gary J Gorbsky
Oklahoma Medical Research Foundation · USStowers Institute for Medical Research · USUniversity of Oklahoma Health Sciences Center · US

Funding

CHROMOSOME MOVEMENT IN PROMETAPHASER01GM050412 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GORBSKY, GARY J. · 1994 to 2012
$4.5M
NIGMS NIH HHS 2R01GM050412NIGMS NIH HHS R01 GM050412
6 · The paper itself

Abstract

Mitosis requires precise coordination of multiple global reorganizations of the nucleus and cytoplasm. Cyclin-dependent kinase 1 (Cdk1) is the primary upstream kinase that directs mitotic progression by phosphorylation of a large number of substrate proteins. Cdk1 activation reaches the peak level due to positive feedback mechanisms. By inhibiting Cdk chemically, we showed that, in prometaphase, when Cdk1 substrates approach the peak of their phosphorylation, cells become capable of proper M-to-G1 transition. We interfered with the molecular components of the Cdk1-activating feedback system through use of chemical inhibitors of Wee1 and Myt1 kinases and Cdc25 phosphatases. Inhibition of Wee1 and Myt1 at the end of the S phase led to rapid Cdk1 activation and morphologically normal mitotic entry, even in the absence of G2. Dampening Cdc25 phosphatases simultaneously with Wee1 and Myt1 inhibition prevented Cdk1/cyclin B kinase activation and full substrate phosphorylation and induced a mitotic "collapse," a terminal state characterized by the dephosphorylation of mitotic substrates without cyclin B proteolysis. This was blocked by the PP1/PP2A phosphatase inhibitor, okadaic acid. These findings suggest that the positive feedback in Cdk activation serves to overcome the activity of Cdk-opposing phosphatases and thus sustains forward progression in mitosis.

Indexed as

MitosisAnimalscdc25 PhosphatasesCDC2 Protein KinaseCell Cycle ProteinsCyclin BCyclin-Dependent KinasesFeedback, PhysiologicalFemaleG2 PhaseGene ExpressionHeLa CellsHumansMembrane ProteinsNuclear ProteinsPhosphoprotein Phosphatasescdc25 PhosphatasesCDC2 Protein KinaseCell Cycle ProteinsCyclin BCyclin-Dependent KinasesMembrane ProteinsMYT1 kinase, XenopusNuclear ProteinsPhosphoprotein PhosphatasesPKMYT1 protein, humanProtein Kinase InhibitorsProtein Phosphatase 2Protein Serine-Threonine KinasesProtein-Tyrosine KinasesWEE1 protein, humanWEE1 protein, XenopusXenopus Proteins

Identifiers

PMID21325631
PMCPMC3078080
OpenAlexW2021278812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.